What are the potential side effects of nomlafobusp?
Category:
CTI-1601
As nomlafobuspis still in Phase 2 clinical testing, information about potential side effects associated with this therapy is still scarce. Available trial data in people with Friedreich’s ataxia indicate that mild to moderate reactions at the injection site were the most common side effects reported to date.